Albert J. Robichaud

4.0k total citations
74 papers, 2.8k citations indexed

About

Albert J. Robichaud is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Albert J. Robichaud has authored 74 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 35 papers in Organic Chemistry and 21 papers in Cellular and Molecular Neuroscience. Recurrent topics in Albert J. Robichaud's work include Neuroscience and Neuropharmacology Research (17 papers), Receptor Mechanisms and Signaling (17 papers) and Chemical synthesis and alkaloids (11 papers). Albert J. Robichaud is often cited by papers focused on Neuroscience and Neuropharmacology Research (17 papers), Receptor Mechanisms and Signaling (17 papers) and Chemical synthesis and alkaloids (11 papers). Albert J. Robichaud collaborates with scholars based in United States, Canada and China. Albert J. Robichaud's co-authors include Kevin G. Liu, Larry E. Overman, G.M. Robertson, James Doherty, Deborah L. Smith, Lee E. Schechter, Gabriel M. Belfort, Michael S. Malamas, A. I. MEYERS and Rebecca Hammond and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Neuroscience and Neurology.

In The Last Decade

Albert J. Robichaud

74 papers receiving 2.7k citations

Peers

Countries citing papers authored by Albert J. Robichaud

Since Specialization

Citations

This map shows the geographic impact of Albert J. Robichaud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Albert J. Robichaud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Albert J. Robichaud more than expected).

Fields of papers citing papers by Albert J. Robichaud

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Albert J. Robichaud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Albert J. Robichaud. The network helps show where Albert J. Robichaud may publish in the future.

Co-authorship network of co-authors of Albert J. Robichaud

This figure shows the co-authorship network connecting the top 25 collaborators of Albert J. Robichaud. A scholar is included among the top collaborators of Albert J. Robichaud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Albert J. Robichaud. Albert J. Robichaud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	SAGE-718: A First-in-ClassN-Methyl-d-Aspartate Receptor Positive Allosteric Modulator for the Potential Treatment of Cognitive Impairment 2022 ·Journal of Medicinal Chemistry ·Matthew D. Hill, María‐Jesús Blanco, Francesco G. Salituro, (unknown), Jacob T. Beckley, Michael A. Ackley, Jing Dai, James Doherty, Boyd L. Harrison, Ethan Hoffmann, Tatiana M. Kazdoba, (unknown), Michael Lewis, Michael C. Quirk, Albert J. Robichaud	28
2	24(S)-Hydroxycholesterol Levels are Decreased in Early Huntington’s Disease and Are Associated with Deficits in Several Cognitive Domains (4070) 2020 ·Neurology ·Michael Lewis, Jing Dai, Amrita Mohan, Sarah J. Tabrizi, James Doherty, Albert J. Robichaud, Michael C. Quirk	4
3	Mechanistic PK/PD Model of Neuroactive Steroid GABAA Positive Allosteric Modulation and Effects on TETRAS Assessment in Essential Tremor (4499) 2020 ·Neurology ·David P. Nguyen, Anne C. Smith, (unknown), E. Hoffman, James Paskavitz, Angela Wehr, (unknown), Amy Bullock, Abdul J. Sankoh, Albert J. Robichaud, Stephen Kanes, James Doherty, Michael C. Quirk	1
4	Allosteric Modalities for Membrane-Bound Receptors: Insights from Drug Hunting for Brain Diseases 2019 ·Journal of Medicinal Chemistry ·(unknown), Allen T. Hopper, María‐Jesús Blanco, Vijaya G. Tirunagaru, Albert J. Robichaud, Darı́o Doller	16
5	Anticonvulsant profile of the neuroactive steroid, SGE-516, in animal models 2017 ·Epilepsy Research ·Rebecca Hammond, Alison L. Althaus, Michael A. Ackley, Carla Maciag, (unknown), Francesco G. Salituro, Albert J. Robichaud, James Doherty	19
6	Rescue of deficient amygdala tonic γ‐aminobutyric acidergic currents in theFmr^–/ymouse model of fragile X syndrome by a novel γ‐aminobutyric acid type A receptor‐positive allosteric modulator 2015 ·Journal of Neuroscience Research ·Brandon S. Martin, Gabriel Martínez-Botella, Carlos M. Loya, Francesco G. Salituro, Albert J. Robichaud, Molly M. Huntsman, (unknown), James Doherty, Jackie D. Corbin	8
7	The Major Brain Cholesterol Metabolite 24(S)-Hydroxycholesterol Is a Potent Allosteric Modulator ofN-Methyl-d-Aspartate Receptors 2013 ·Journal of Neuroscience ·Steven M. Paul, James Doherty, Albert J. Robichaud, Gabriel M. Belfort, Brian Y. Chow, Rebecca Hammond, Devon C. Crawford, (unknown), Hong‐Jin Shu, Yukitoshi Izumi, Steven Mennerick, Charles F. Zorumski	215
8	Fused thiazolyl alkynes as potent mGlu5 receptor positive allosteric modulators 2013 ·Bioorganic & Medicinal Chemistry Letters ·Mathivanan Packiarajan, (unknown), (unknown), Allen T. Hopper, Andrew D. White, Gamini Chandrasena, (unknown), Robbin Brodbeck, Albert J. Robichaud	6
9	Azetidinyl oxadiazoles as potent mGluR5 positive allosteric modulators 2012 ·Bioorganic & Medicinal Chemistry Letters ·Mathivanan Packiarajan, (unknown), (unknown), Andrew D. White, Gamini Chandrasena, (unknown), Robbin Brodbeck, Albert J. Robichaud	12
10	N-Aryl pyrrolidinonyl oxadiazoles as potent mGluR5 positive allosteric modulators 2012 ·Bioorganic & Medicinal Chemistry Letters ·Mathivanan Packiarajan, (unknown), (unknown), Andrew D. White, Gamini Chandrasena, (unknown), Robbin Brodbeck, Albert J. Robichaud	17
11	New pyrazolyl and thienyl aminohydantoins as potent BACE1 inhibitors: Exploring the S2′ region 2011 ·Bioorganic & Medicinal Chemistry Letters ·Michael S. Malamas, (unknown), Iwan Gunawan, Keith D. Barnes, Hui Yu, Matthew R. Johnson, Albert J. Robichaud, Ping Zhou, Yinfa Yan, (unknown), Jim Turner, Kristi Fan, Rajiv Chopra, Jonathan Bard, Menelas N. Pangalos	24
12	Identification of 3-sulfonylindazole derivatives as potent and selective 5-HT6 antagonists 2010 ·Bioorganic & Medicinal Chemistry ·Kevin G. Liu, Albert J. Robichaud, (unknown), (unknown), (unknown), James F. Mattes, Yanxuan Cai, (unknown), (unknown), Dianne Kowal, Deborah L. Smith, Li Di, Edward H. Kerns, Lee E. Schechter, Thomas A. Comery	19
13	1-(2-Aminoethyl)-3-(arylsulfonyl)-1H-pyrrolopyridines are 5-HT6 receptor ligands 2009 ·Bioorganic & Medicinal Chemistry Letters ·Ronald C. Bernotas, Schuyler Antane, (unknown), Simon N. Haydar, Albert J. Robichaud, Boyd L. Harrison, (unknown), Deborah L. Smith, Joseph Coupet, Lee E. Schechter	8
14	Novel 1-aminoethyl-3-arylsulfonyl-1H-pyrrolo[2,3-b]pyridines are potent 5-HT6 agonists 2009 ·Bioorganic & Medicinal Chemistry ·Ronald C. Bernotas, (unknown), Schuyler Antane, Derek C. Cole, Boyd L. Harrison, Albert J. Robichaud, (unknown), Deborah L. Smith, Brian J. Platt, Qian Lin, Ping Li, Joseph Coupet, Sharon Rosenzweig‐Lipson, Chad E. Beyer, Lee E. Schechter	15
15	Identification of a novel series of 3-piperidinyl-5-sulfonylindazoles as potent 5-HT6 ligands 2009 ·Bioorganic & Medicinal Chemistry Letters ·Kevin G. Liu, (unknown), Thomas A. Comery, (unknown), (unknown), Dianne Kowal, Deborah L. Smith, Li Di, Edward H. Kerns, Lee E. Schechter, Albert J. Robichaud	9
16	3,4-Dihydropyrimido(1,2-a)indol-10(2H)-ones as potent non-peptidic inhibitors of caspase-3 2009 ·Bioorganic & Medicinal Chemistry ·(unknown), (unknown), Wayne E. Childers, (unknown), Arlene Dietrich, Boyd L. Harrison, Vasilios M. Marathias, Gregory J. Tawa, Ann Aulabaugh, Rebecca Cowling, (unknown), Weixin Xu, Lidia Mosyak, F. Moy, Wah-Tung Hum, Andrew Wood, Albert J. Robichaud	18
17	Di-substituted pyridinyl aminohydantoins as potent and highly selective human β-secretase (BACE1) inhibitors 2009 ·Bioorganic & Medicinal Chemistry ·Michael S. Malamas, Keith D. Barnes, Matthew R. Johnson, Hui Yu, Ping Zhou, Jim Turner, Yun Hu, Erik Wagner, Kristi Fan, Rajiv Chopra, Andrea Olland, Jonathan Bard, Menelas N. Pangalos, Peter H. Reinhart, Albert J. Robichaud	38
18	Novel 1-(azacyclyl)-3-arylsulfonyl-1H-pyrrolo[2,3-b]pyridines as 5-HT6 agonists and antagonists 2007 ·Bioorganic & Medicinal Chemistry ·Hassan Elokdah, David Li, (unknown), Ronald C. Bernotas, Albert J. Robichaud, Ronald L. Magolda, (unknown), Deborah L. Smith, Lee E. Schechter	13
19	4-(2-Aminoethoxy)-N-(phenylsulfonyl)indoles as novel 5-HT6 receptor ligands 2005 ·Bioorganic & Medicinal Chemistry Letters ·Ping Zhou, Yinfa Yan, Ronald C. Bernotas, Boyd L. Harrison, Donna M. Huryn, Albert J. Robichaud, (unknown), Deborah L. Smith, Lee E. Schechter	18
20	Solid-Phase Synthesis of Alkyl Aryl Ethers via the Ullmann Condensation 2002 ·Journal of Combinatorial Chemistry ·Xiao Xiao, Rongshi Li, David C. Hurst, Hui Zhuang, Shuhao Shi, Anthony W. Czarnik, Albert J. Robichaud, Dean A. Wacker, David W. Robertson	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact